DOCSLIB.ORG

Acetylcholine Receptors 61 Acid Blob Activator 321 Acquired Immune

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Acetylcholine Receptors 61 Acid Blob Activator 321 Acquired Immune WBVINDEX 6/27/03 11:39 PM Page 428 Index Note: page numbers in italics refer to figures, those in bold refer to tables. Illustrations in the Plate Section are indicated by Plate number. acetylcholine receptors 61 AIDS 5, 40, 89 Fc region 168, 172, 173, 174, acid blob activator 321 development 332 175–6 acquired immune deficiency enabling factors for disease 386 measurement of antiviral 91–5 syndrome see AIDS immune dysfunction 86–7 structure 167–8 actin fibers, HSV-induced changes impact 383, 384–5 antibody–antigen complexes 93–4 134, 135 Kaposi’s sarcoma 332 bacterial proteins for detection/ acycloguanosine (acG) 107, 108 protease inhibitors 235 isolation 173–4, 174–5 acyclovir 107, 108 T cell destruction 372 antigen(s), viral 18, 39, 77 adeno-associated virus (AAV) see also HIV antibodies bound to 172–3 305–6 alfalfa looper virus (AcNPV) 333, internalization 85 gene delivery 388 334 processing 82–3, 83–4 latent infection 306, 389 algal viruses 351–2 vaccine production 101 cyclic adenosine monophosphate Alzheimer’s disease, gene therapy antigen presentation (cAMP) 199 389 to immune reactive cells 80–6 adenovirus 23, 38 amantadine 108–9 local immunity 82 capsid amino acid epitopes 78, 79, 81 antigen presenting cells (APCs) 77, proteins 149, 150, 151 aminopterin 170 78 structure 301 cAMP receptor protein (CRP) immune response initiation DNA 287 199 82–5 replication 301–3 amplification, viral 24 professional 83 E1A gene 301, 302 aneuploidy 129 antigenic determinants 78, 81 E1B protein 301, 302 animal cells 11, 12 antigenic drift 88 E2 region 301, 302 culture 128–31 influenza A 270 gene delivery 388 surface 62 antigenic shift, influenza A genome 301, 302 transformation 11, 13 271 host interactions 303 animal models antisense oligonucleotides 110 polyadenylation site use changes herpes simplex virus 33–4 antiserum 167 303 parameters 27 antiviral antibody measurement replication 135, 299, 301–3, pathogenesis 25–34 91–5 304 poxvirus 27–8 antiviral drugs 106–10 serotypes 88 rabies 30–1, 31–2 antisense 110 transformation of nonpermissive reovirus 28–30 HIV protease targeting 73 cells 303 animal pathogens 7 precise targeting 110 tumor suppressor gene function animal viruses, entry into cells 61, resistance reduction/elimination blocking 371 62, 63–4 109–10 VA RNA 301, 303 antibiotic resistance 90 targeting to virus replication cycle adjuvants 101 antibodies 77 106–10 aerosol, viral 19, 21, 24 antigen-bound 172–3 therapeutic index 106 agnoproteins 294, 295 Fab region 167 toxicity 106 WBVINDEX 6/27/03 4:16 PM Page 429 INDEX 429 antiviral effector molecules (AVEMs) genome 348 replication 272, 273, 274–5 104, 105 size 157, 158 ribonucleoproteins 273, 274 apathogenic strains 4 host cell lysis/lysogeny 346, 348, structure 272, 273 apoptosis 38, 104, 370 349, 350 vectors 272 adenovirus 303 decision in E. coli 350–1 buoyant density differences 145–6 arboviruses 42–3, 57 latency 346, 348–50 buried determinants 79 see also arthropod vectors; promoters 348–9, 350–1 Burkitt’s lymphoma 332, 371 bunyaviruses; togaviruses prophage generation 350 burst size 11 arenaviruses 275–6 reactivation 346, 348–50 arthropod vectors 22, 24, 57 replication 346, 348–50 C-proteases 235 bunyaviruses 272, 275 termination signals 349 Cadang-Cadang viroid 7, 23, 281 spread 386 bacteriophage P22 72–3 cAMP receptor protein (CRP) 199 togaviruses 247 bacteriophage Qb 253–5 cancer 19, 370–1 arthropods, viral infections 333 bacteriophage T4 343–6, 347 cervical carcinoma 370 atomic force microscopy 123–4 assembly 347 hepatocellular carcinoma 19, attachment, viral 60 capsid maturation/release 346, 371, 380 attenuation 98, 100 347 human gamma herpesviruses 312 viral genome 219 DNA genome 151, 152, 343–4, oncornavirus transformation 370 autoimmune disease 87–8 345 persistent infections 39 persistent infections 39 genome 343–5 retrovirus-induced 371 avian influenza replication 345–6, 347 see also carcinogenesis; oncogenes; in chickens 7 structure 344 oncogenesis transmission to humans 272, 384 bacteriophage T7 342–3 cancer cells 11, 13 avian leukosis virus 361 baculovirus 333–4 primary cell transformation 131 avirulent strains 4 RNA polymerase encoding 200 canine distemper 264 azidothymidine (AZT) 108, 109 Baltimore classification 57, 58, 232 cap-binding protein (CBP1) 202 biochemical processes 9 cap site 188, 190, 191, 192 B-cell immunity see humoral biological activity, viral, cap snatching/stealing 268, 269 immunity measurement 136–42 capillary electrophoresis 152 B cells 17, 83 biological control, baculovirus 334 capsid proteins antibody production 77 biological weapons testing by US differing molar amounts 149, clonal selection 85, 86 387 150, 151 effector 19 biotechnology, baculovirus 334 poliovirus 148–9, 150 Epstein–Barr virus 18, 331 bioterrorism 7, 386–7 stoichiometry 147–8 immune response 80 smallpox research 98 capsids 51, 52, 53, 55 internalizing 85 threats 98, 341 assembly 69, 71–3, 74, 75 maturation 80 BK virus 38, 288–9, 291 budding 75 monoclonal antibodies 168, 169, blood empty 72, 132, 239, 240 170 hepatitis C virus transmission 43 formation 60 bacterial antiviral systems 110–11 pooled fractions 5 helical 69, 71 bacterial cells 11, 12 titers of virus 19 icosahedral 71–3 cultures 127–8 blood products 5, 6 symmetry 52, 55 viral infections 14 hepatitis C virus transmission 43 capsomer 52 bacterial restriction 14, 110–11 blood transfusions 5, 6 self-assembly 71 bacterial transposons 373 blood–brain barrier 41 carcinogenesis 370–1 bacterial viruses 276 bluetongue virus 279 catabolite repression 199 bacteriophage 6 bornaviruses 258, 259, 266–7 cattle prion disease see bovine DNA injection into E. coli 67, 68, bovine spongiform encephalopathy spongiform encephalopathy 69 (BSE) 10, 282, 283 (BSE) large DNA-containing 342–6, brome mosaic virus 66 cauliflower mosaic virus 380–1 347, 348–51 replication 252–3 CCR5 63, 372 mRNA regulated translation BstEII restriction endonuclease 157, CD4+ 18 253–5 158 CD4 receptor 390 RNA genome replication 253–5 bunyaviruses 23 CD4+ T cells 61, 63, 83, 372 bacteriophage FX174 307–9 ambisense genomes 274 CD8+ T cells 82 bacteriophage l encephalitis 275 cell(s) cro protein 349, 350 gene products 273, 274 antigenicity change 134 DNA integration 350 hemorrhagic fever 275 biochemical property changes gene expression 348–50 pathogenesis 275 135–6 WBVINDEX 6/27/03 4:16 PM Page 430 430 INDEX cell(s) (cont’d ) coconut palm loss 7 developing world contact inhibition of growth 130 cold virus 19, 21, 37, 241 AIDS spread 5 fusion 134 isolated communities 24–5 vaccines 100, 102 immortal 170 Colorado tick fever virus 279 diabetes mellitus 19 infection outcome 131–6 Coltivirus 279 dideoxycytidine (ddC) 109 lysis 61 communications, disease spread 386 dideoxyinosine (ddI) 109 complement-mediated 85–6, complement cascade 85–6, 87 differential display analysis 136 87 complement fixation 93–5 dilution endpoint methods 140, morphology change 134, 135 complementary DNA (cDNA) 136, 141–2 nonpermissive 131–2 159–60 disease 14 physical appearance change fluorescent-tagged molecules 183 acute infections 36–7 133–4, 135 sequence analysis 195–6 animal models 26–7 transformed foci generation 137, complementation, mutations 216, bunyavirus 275 138 217 causes 385–6 tropism 40 confocal microscopy 170–1, 172, coronavirus 251 viral entry 60 Plates 7 and 8 elimination 387 animal viruses 61, 62, 63–4 contact inhibition of growth 130 emerging 383–7 enveloped 64–5 coronavirus 23, 37 enabling factors 385–6 nonenveloped 64 cytopathology 251 etiology 59 plant viruses 65–7 replication/transcription 248–50 human history impact 6–7 viral genome introduction 69, 70 cowpea mosaic virus replication 252 long incubation periods 39–40 cell culture techniques 127–31 cowpox 97–8, 338, 341 modes of spread of human viruses cell lines coxsackievirus 241 21, 22 continuous 128–9, 130, 131 Creutzfeldt–Jakob disease 10, 282 novel virus strain evolution 385 primary 129–30, 131 variant 10, 283 picornavirus 239–41 transformed 130, 131 cro protein 349, 350 poliovirus 239–41 cell-mediated immunity 77 cryo-electron microscopy 121, 122 rhabdoviruses 264 measurement 90–1 CXCR4 63, 372, 390 sources 385–6 central nervous system (CNS) 177, cytochalasin B 234 subviral 39–40 178 cytokines 103, 370 symptoms 17–18, 19 herpes simplex virus 30 see also interferon (IFN) togavirus 246–8 infection target 40, 41 cytolysis 61 viral destruction of other viruses microglial cells 18 cytomegalovirus (CMV) see human 390 polyomavirus 291 cytomegalovirus (HCMV) distemper 264, 265 rabies virus 30–1, 31–2 cytopathic effect (CPE) 141 DNA 51 viral spread 17 cytopathology 61 amplification with PCR 160–3 centrifugation, rate zonal 146, biochemical properties of cells automated sequencing 153–4, 156–7 135–6 155, Plate 5 cervical carcinoma 370 coronavirus 251 bacterial chromosome 186 chemokines 18, 63 picornavirus 239–41 base polarity 186 receptors 372 plaque formation 136, 137 chemical sequencing 152–3 chicken pox 19, 23, 24, 312 poliovirus 239–41 cleavage with restriction see also varicella zoster virus rhabdoviruses 264 endonuclease 208–10 Chlorella viruses 8, 351–2 togavirus 246–8 complexity measurement 158–60 chloroplast 8 virus-mediated 133–4, 135 denatured bubble 186–7 chorioallantoic membrane, plaque cytotoxic T cells 370 duplex 186 formation 136 enzymatic sequencing 153, chromosomal translocation, Dane particles 377 154–5 virus-induced 371 defective interfering (DI) particles eukaryotic 186 cI protein 351 223 fragment cloning 212–13, circulatory system, viral spread 17 see also virus particles, defective 214–15 cirrhosis 44, 385
Load more

Recommended publications
  • Metagenomic Analysis Indicates That Stressors Induce Production of Herpes-Like Viruses in the Coral Porites Compressa
    Metagenomic analysis indicates that stressors induce production of herpes-like viruses in the coral Porites compressa Rebecca L. Vega Thurbera,b,1, Katie L. Barotta, Dana Halla, Hong Liua, Beltran Rodriguez-Muellera, Christelle Desnuesa,c, Robert A. Edwardsa,d,e,f, Matthew Haynesa, Florent E. Anglya, Linda Wegleya, and Forest L. Rohwera,e aDepartment of Biology, dComputational Sciences Research Center, and eCenter for Microbial Sciences, San Diego State University, San Diego, CA 92182; bDepartment of Biological Sciences, Florida International University, 3000 North East 151st, North Miami, FL 33181; cUnite´des Rickettsies, Unite Mixte de Recherche, Centre National de la Recherche Scientifique 6020. Faculte´deMe´ decine de la Timone, 13385 Marseille, France; and fMathematics and Computer Science Division, Argonne National Laboratory, Argonne, IL 60439 Communicated by Baruch S. Blumberg, Fox Chase Cancer Center, Philadelphia, PA, September 11, 2008 (received for review April 25, 2008) During the last several decades corals have been in decline and at least established, an increase in viral particles within dinoflagellates has one-third of all coral species are now threatened with extinction. been hypothesized to be responsible for symbiont loss during Coral disease has been a major contributor to this threat, but little is bleaching (25–27). VLPs also have been identified visually on known about the responsible pathogens. To date most research has several species of scleractinian corals, specifically: Acropora muri- focused on bacterial and fungal diseases; however, viruses may also cata, Porites lobata, Porites lutea, and Porites australiensis (28). Based be important for coral health. Using a combination of empirical viral on morphological characteristics, these VLPs belong to several viral metagenomics and real-time PCR, we show that Porites compressa families including: tailed phages, large filamentous, and small corals contain a suite of eukaryotic viruses, many related to the (30–80 nm) to large (Ͼ100 nm) polyhedral viruses (29).
    [Show full text]
  • How Influenza Virus Uses Host Cell Pathways During Uncoating
    cells Review How Influenza Virus Uses Host Cell Pathways during Uncoating Etori Aguiar Moreira 1 , Yohei Yamauchi 2 and Patrick Matthias 1,3,* 1 Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland; [email protected] 2 Faculty of Life Sciences, School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK; [email protected] 3 Faculty of Sciences, University of Basel, 4031 Basel, Switzerland * Correspondence: [email protected] Abstract: Influenza is a zoonotic respiratory disease of major public health interest due to its pan- demic potential, and a threat to animals and the human population. The influenza A virus genome consists of eight single-stranded RNA segments sequestered within a protein capsid and a lipid bilayer envelope. During host cell entry, cellular cues contribute to viral conformational changes that promote critical events such as fusion with late endosomes, capsid uncoating and viral genome release into the cytosol. In this focused review, we concisely describe the virus infection cycle and highlight the recent findings of host cell pathways and cytosolic proteins that assist influenza uncoating during host cell entry. Keywords: influenza; capsid uncoating; HDAC6; ubiquitin; EPS8; TNPO1; pandemic; M1; virus– host interaction Citation: Moreira, E.A.; Yamauchi, Y.; Matthias, P. How Influenza Virus Uses Host Cell Pathways during 1. Introduction Uncoating. Cells 2021, 10, 1722. Viruses are microscopic parasites that, unable to self-replicate, subvert a host cell https://doi.org/10.3390/ for their replication and propagation. Despite their apparent simplicity, they can cause cells10071722 severe diseases and even pose pandemic threats [1–3].
    [Show full text]
  • On the Biological Success of Viruses
    MI67CH25-Turner ARI 19 June 2013 8:14 V I E E W R S Review in Advance first posted online on June 28, 2013. (Changes may still occur before final publication E online and in print.) I N C N A D V A On the Biological Success of Viruses Brian R. Wasik and Paul E. Turner Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut 06520-8106; email: [email protected], [email protected] Annu. Rev. Microbiol. 2013. 67:519–41 Keywords The Annual Review of Microbiology is online at adaptation, biodiversity, environmental change, evolvability, extinction, micro.annualreviews.org robustness This article’s doi: 10.1146/annurev-micro-090110-102833 Abstract Copyright c 2013 by Annual Reviews. Are viruses more biologically successful than cellular life? Here we exam- All rights reserved ine many ways of gauging biological success, including numerical abun- dance, environmental tolerance, type biodiversity, reproductive potential, and widespread impact on other organisms. We especially focus on suc- cessful ability to evolutionarily adapt in the face of environmental change. Viruses are often challenged by dynamic environments, such as host immune function and evolved resistance as well as abiotic fluctuations in temperature, moisture, and other stressors that reduce virion stability. Despite these chal- lenges, our experimental evolution studies show that viruses can often readily adapt, and novel virus emergence in humans and other hosts is increasingly problematic. We additionally consider whether viruses are advantaged in evolvability—the capacity to evolve—and in avoidance of extinction. On the basis of these different ways of gauging biological success, we conclude that viruses are the most successful inhabitants of the biosphere.
    [Show full text]
  • Ebolaviruses: New Roles for Old Proteins
    REVIEW Ebolaviruses: New roles for old proteins Diego Cantoni, Jeremy S. Rossman* School of Biosciences, University of Kent, Canterbury, United Kingdom * [email protected] Abstract In 2014, the world witnessed the largest Ebolavirus outbreak in recorded history. The subse- quent humanitarian effort spurred extensive research, significantly enhancing our under- standing of ebolavirus replication and pathogenicity. The main functions of each ebolavirus protein have been studied extensively since the discovery of the virus in 1976; however, the recent expansion of ebolavirus research has led to the discovery of new protein functions. a1111111111 These newly discovered roles are revealing new mechanisms of virus replication and patho- a1111111111 genicity, whilst enhancing our understanding of the broad functions of each ebolavirus viral a1111111111 a1111111111 protein (VP). Many of these new functions appear to be unrelated to the protein's primary a1111111111 function during virus replication. Such new functions range from bystander T-lymphocyte death caused by VP40-secreted exosomes to new roles for VP24 in viral particle formation. This review highlights the newly discovered roles of ebolavirus proteins in order to provide a more encompassing view of ebolavirus replication and pathogenicity. OPEN ACCESS Citation: Cantoni D, Rossman JS (2018) Ebolaviruses: New roles for old proteins. PLoS Negl Trop Dis 12(5): e0006349. https://doi.org/ Author summary 10.1371/journal.pntd.0006349 Between 2014 and 2016, West Africa experienced the largest Ebolavirus outbreak in Editor: Patricia V. Aguilar, University of Texas recorded history. The international containment effort spurred extensive research that is Medical Branch, UNITED STATES enhancing our understanding of ebolavirus replication and pathogenicity.
    [Show full text]
  • The Complete Genome of an Endogenous Nimavirus (Nimav-1 Lva) from the Pacific Whiteleg Shrimp Penaeus (Litopenaeus) Vannamei
    G C A T T A C G G C A T genes Article The Complete Genome of an Endogenous Nimavirus (Nimav-1_LVa) From the Pacific Whiteleg Shrimp Penaeus (Litopenaeus) Vannamei Weidong Bao 1,* , Kathy F. J. Tang 2 and Acacia Alcivar-Warren 3,4,* 1 Genetic Information Research Institute, 20380 Town Center Lane, Suite 240, Cupertino, CA 95014, USA 2 Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, 106 Nanjing Road, Qingdao 266071, China; [email protected] 3 Fundación para la Conservation de la Biodiversidad Acuática y Terrestre (FUCOBI), Quito EC1701, Ecuador 4 Environmental Genomics Inc., ONE HEALTH Epigenomics Educational Initiative, P.O. Box 196, Southborough, MA 01772, USA * Correspondence: [email protected] (W.B.); [email protected] (A.A.-W.) Received: 17 December 2019; Accepted: 9 January 2020; Published: 14 January 2020 Abstract: White spot syndrome virus (WSSV), the lone virus of the genus Whispovirus under the family Nimaviridae, is one of the most devastating viruses affecting the shrimp farming industry. Knowledge about this virus, in particular, its evolution history, has been limited, partly due to its large genome and the lack of other closely related free-living viruses for comparative studies. In this study, we reconstructed a full-length endogenous nimavirus consensus genome, Nimav-1_LVa (279,905 bp), in the genome sequence of Penaeus (Litopenaeus) vannamei breed Kehai No. 1 (ASM378908v1). This endogenous virus seemed to insert exclusively into the telomeric pentanucleotide microsatellite (TAACC/GGTTA)n. It encoded 117 putative genes, with some containing introns, such as g012 (inhibitor of apoptosis, IAP), g046 (crustacean hyperglycemic hormone, CHH), g155 (innexin), g158 (Bax inhibitor 1 like).
    [Show full text]
  • JOURNAL of VIROLOGY VOLUME 57 * MARCH 1986 * NUMBER 3 Arnold J
    JOURNAL OF VIROLOGY VOLUME 57 * MARCH 1986 * NUMBER 3 Arnold J. Levine, Editor in Chief Michael B. A. Oldstone, Editor (1988) (1989) Scripps Clinic & Research Foundation Princeton University La Jolla, Calif. Princeton, N.J. Thomas E. Shenk, Editor (1989) David T. Denhardt, Editor (1987) Princeton University University of Western Ontario Princeton, N.J. London, Ontario, Canada Anna Marie Skalka, Editor (1989) Bernard N. Fields, Editor (1988) Hoffmann-La Roche Inc. Harvard Medical School Nutley, N.J. Boston, Mass. Robert A. Weisberg, Editor (1988) Robert M. Krug, Editor (1987) National Institute of Child Health Sloan-Kettering Institute and Human Development New York, N.Y. Bethesda, Md. EDITORIAL BOARD James Alwine (1988) Hidesaburo Hanafusa (1986) Lois K. Miller (1988) Priscilla A. Schaffer (1987) David Baltimore (1987) William S. Hayward (1987) Peter Model (1986) Sondra Schlesinger (1986) Tamar Ben-Porat (1987) Roger Hendrix (1987) Bernard Moss (1986) Manfred Schubert (1988) Kenneth I. Berns (1988) Martin Hirsch (1986) Fred Murphy (1986) June R. Scott (1986) Michael Botchan (1986) John J. Holland (1987) Opendra Narayan (1988) Bart Sefton (1988) Thomas J. Braciale (1988) Ian H. Holmes (1986) Joseph R. Nevins (1988) Charles J. Sherr (1987) Joan Brugge (1988) Robert W. Honess (1986) Nancy G. Nossal (1987) Saul J. Silverstein Barrie J. Carter (1987) Nancy Hopkins (1986) Abner Notkins (1986) (1988) John M. Coffin (1986) Peter M. Howley (1987) J. Thomas Parsons (1986) Patricia G. Spear (1987) Geoffrey M. Cooper (1987) Alice S. Huang (1987) Ulf G. Pettersson (1986) Nat Sternberg (1986) Donald Court (1987) Steve Hughes (1988) Lennart Philipson (1987) Bruce Stillman (1988) Richard Courtney (1986) Tony Hunter (1986) Lewis I.
    [Show full text]
  • A Novel RNA Virus in the Parasitoid Wasp Lysiphlebus Fabarum: Genomic Structure, Prevalence, and Transmission
    viruses Article A Novel RNA Virus in the Parasitoid Wasp Lysiphlebus fabarum: Genomic Structure, Prevalence, and Transmission 1,2, , 1,2 1,2, Martina N. Lüthi * y , Christoph Vorburger and Alice B. Dennis z 1 Institute of Integrative Biology, ETH Zürich, Universitätstrasse 16, 8092 Zürich, Switzerland; [email protected] (C.V.); [email protected] (A.B.D.) 2 Eawag, Swiss Federal Institute of Aquatic Science and Technology, Überlandstrasse 133, 8600 Dübendorf, Switzerland * Correspondence: [email protected] Current address: Institute of Plant Sciences, University of Bern, Altenbergrain 21, 3013 Bern, Switzerland. y Current address: Institute of Biochemistry and Biology, University of Potsdam, Karl-Liebknecht-Strasse z 24–25, 14476 Potsdam, Germany. Received: 17 November 2019; Accepted: 31 December 2019; Published: 3 January 2020 Abstract: We report on a novel RNA virus infecting the wasp Lysiphlebus fabarum, a parasitoid of aphids. This virus, tentatively named “Lysiphlebus fabarum virus” (LysV), was discovered in transcriptome sequences of wasps from an experimental evolution study in which the parasitoids were allowed to adapt to aphid hosts (Aphis fabae) with or without resistance-conferring endosymbionts. Based on phylogenetic analyses of the viral RNA-dependent RNA polymerase (RdRp), LysV belongs to the Iflaviridae family in the order of the Picornavirales, with the closest known relatives all being parasitoid wasp-infecting viruses. We developed an endpoint PCR and a more sensitive qPCR assay to screen for LysV in field samples and laboratory lines. These screens verified the occurrence of LysV in wild parasitoids and identified the likely wild-source population for lab infections in Western Switzerland. Three viral haplotypes could be distinguished in wild populations, of which two were found in the laboratory.
    [Show full text]
  • Eesha Acharya Project #1
    Eesha Acharya Project #1 Completed Project, Science, Health and Medical Measuring Vitamin C Levels in Cooked Foods Most people know that raw foods contain the most nutrients. However, many people prefer eating cooked foods. the problem is vitamin C is a water-soluble vitamin, so when foods are cooked they lose a lot of this essential nutrient. The purpose of this research is to determine which cooking method best retains the most vitamin C in vegetables. The raw vegetable vitamin C information will be compared to that of other cooking methods (grilling, boiling, and steaming) of that same vegetable. tomatoes, brussel sprouts, kale, bell peppers, broccoli, peas, and a tincture of iodine solution, 2-7% elemental iodine, will be used to test the vitamin C content. The food will be tested by mixing 10g of food to a starch-water mixture and straining the water. Drops of iodine will be added to the strained water until the solution turns black. The more iodine added, means the more vitamin C is in the food. Then the number of drops will be divided by 10g of food. This gives the drops per gram of food. This number will be multiplied by the factor. The drops per gram multiplied by the factor equals mg of vitamin C per gram of food This study is designed to help people consume more vitamin C. Many people in the United States have a vitamin C deficiency. Vitamin C is a key that prevents immune system deficiency and cardiovascular disease. So if a proper cooking method can be found, then people can consume more Vitamin C.
    [Show full text]
  • Journal of Virology
    JOURNAL OF VIROLOGY Volume 68 November 1994 No. 11 MINIREVIEW Molecular Biology of the Human Immunodeficiency Virus Ramu A. Subbramanian and Eric 6831-6835 Accessory Proteins A. Cohen ANIMAL VIRUSES Monoclonal Antibodies against Influenza Virus PB2 and NP J. Baircena, M. Ochoa, S. de la 6900-6909 Polypeptides Interfere with the Initiation Step of Viral Luna, J. A. Melero, A. Nieto, J. mRNA Synthesis In Vitro Ortin, and A. Portela Low-Affinity E2-Binding Site Mediates Downmodulation of Frank Stubenrauch and Herbert 6959-6966 E2 Transactivation of the Human Papillomavirus Type 8 Pfister Late Promoter Template-Dependent, In Vitro Replication of Rotavirus RNA Dayue Chen, Carl Q.-Y. Zeng, 7030-7039 Melissa J. Wentz, Mario Gorziglia, Mary K. Estes, and Robert F. Ramig Improved Self-Inactivating Retroviral Vectors Derived from Paul Olson, Susan Nelson, and 7060-7066 Spleen Necrosis Virus Ralph Dornburg Isolation of a New Foamy Retrovirus from Orangutans Myra 0. McClure, Paul D. 7124-7130 Bieniasz, Thomas F. Schulz, Ian L. Chrystie, Guy Simpson, Adriano Aguzzi, Julian G. Hoad, Andrew Cunningham, James Kirkwood, and Robin A. Weiss Cell Lines Inducibly Expressing the Adeno-Associated Virus Christina Holscher, Markus Horer, 7169-7177 (AAV) rep Gene: Requirements for Productive Replication Jurgen A. Kleinschmidt, of rep-Negative AAV Mutants Hanswalter Zentgraf, Alexander Burkle, and Regine Heilbronn Role of Flanking E Box Motifs in Human Immunodeficiency S.-H. Ignatius Ou, Leon F. 7188-7199 Virus Type 1 TATA Element Function Garcia-Martinez, Eyvind J. Paulssen, and Richard B. Gaynor Characterization and Molecular Basis of Heterogeneity of Fernando Rodriguez, Carlos 7244-7252 the African Swine Fever Virus Envelope Protein p54 Alcaraz, Adolfo Eiras, Rafael J.
    [Show full text]
  • Downloads/ Hsp90interactors.Pdf), and Tend to Be Metastable, Being Rapidly Degraded Upon Hsp90 Inhibition
    viruses Review Chaperoning the Mononegavirales: Current Knowledge and Future Directions Victor Latorre †, Florian Mattenberger † and Ron Geller * Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, 46980 Valencia, Spain; [email protected] (V.L.); [email protected] (F.M.) * Correspondence: [email protected]; Tel.: +34-963-543-187 † These authors contributed equally to this work. Received: 16 November 2018; Accepted: 5 December 2018; Published: 8 December 2018 Abstract: The order Mononegavirales harbors numerous viruses of significant relevance to human health, including both established and emerging infections. Currently, vaccines are only available for a small subset of these viruses, and antiviral therapies remain limited. Being obligate cellular parasites, viruses must utilize the cellular machinery for their replication and spread. Therefore, targeting cellular pathways used by viruses can provide novel therapeutic approaches. One of the key challenges confronted by both hosts and viruses alike is the successful folding and maturation of proteins. In cells, this task is faced by cellular molecular chaperones, a group of conserved and abundant proteins that oversee protein folding and help maintain protein homeostasis. In this review, we summarize the current knowledge of how the Mononegavirales interact with cellular chaperones, highlight key gaps in our knowledge, and discuss the potential of chaperone inhibitors as antivirals. Keywords: Mononegavirales; chaperones; antivirals; Hsp70;
    [Show full text]
  • Structure of the Cleavage-Activated Prefusion Form of the Parainfluenza Virus 5 Fusion Protein
    Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein Brett D. Welcha,b,1, Yuanyuan Liua,b,1, Christopher A. Korsa,b, George P. Lesera,b, Theodore S. Jardetzkyc,2, and Robert A. Lamba,b,2 aHoward Hughes Medical Institute and bDepartment of Molecular Biosciences, Northwestern University, Evanston, IL 60208; and cDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305 Contributed by Robert A. Lamb, August 9, 2012 (sent for review June 28, 2012) The paramyxovirus parainfluenza virus 5 (PIV5) enters cells by refolding, resulting in formation of a trimeric coiled coil com- fusion of the viral envelope with the plasma membrane through posed of a heptad repeat A region that extends away from the the concerted action of the fusion (F) protein and the receptor viral membrane (18–20). binding protein hemagglutinin-neuraminidase. The F protein folds Peptide inhibitor studies and available atomic structures in- initially to form a trimeric metastable prefusion form that is trig- dicate that many of the key elements of this entry mechanism are gered to undergo large-scale irreversible conformational changes common to other class I viral fusion proteins, such as the hem- to form the trimeric postfusion conformation. It is thought that agglutinin (HA) of influenza virus, gp120/41 of HIV, S protein of F refolding couples the energy released with membrane fusion. severe acute respiratory syndrome coronavirus, and glycoprotein The F protein is synthesized as a precursor (F0) that must be (GP) of Ebola virus (reviewed in ref. 4). Although X-ray struc- cleaved by a host protease to form a biologically active molecule, tures of the six-helix bundle of many type I fusion proteins have F1,F2.
    [Show full text]
  • Gifc-2018 Book of Abstracts
    GIFC-2018 Giornate Italo-Francesi di Chimica Journées Franco-Italiennes de Chimie 16 – 18 April 2018 Grand Hotel Savoia Via Arsenale di Terra, 5 Genova BOOK OF ABSTRACTS ISBN: 978-88-94952-00-1 Gold Sponsors Silver Sponsors Patronages 2 3 Scientific Program 4 5 6 List of Posters (according to alphabetic order of presenting Authors) 1st session, Monday 16th April Num Cognome Nome Contatto Titolo Synthesis, purification and characterization of PO1 Aboudou Soioulata [email protected] antimicrobial peptides isolated from animal venoms [email protected] PO2 Ajmalghan Muthali Coverage dependent recombination mechanisms of hydrogen from niv-amu.fr tungsten surfaces via density functional theory Hybrid squaraine-silica nanoparticles as nir probes for biological PO3 Alberto Gabriele [email protected] applications: optimization of the photoemission performances Synthesis of doped metal oxide nanocrystals for solution-processed PO4 Alkarsifi Riva [email protected] interfacial layers in organic solar cells PO5 Anceschi Anastasia [email protected] Maltodextrins nanosponges as precursor for porous carbon materials [email protected] PO7 Arnodo Davide First racemic total synthesis of heliolactone .it [email protected]. PO8 Azzi Emanuele Synthesis of boronated analogue of curcumin as potential therapeutical it agents for alzheimer’s disease Study of Nanobiomaterials with Bio-based Antioxidants: Interaction of PO9 Barzan Giulia Sci piem Polyphenol Molecules with Hydroxyapatite and Silica Luigi Methotrexate loaded solid lipid nanoparticles: protein functionalization to PO10 Battaglia [email protected] Sebastiano improve brain biodistribution [email protected] PO11 Begni Federico On the adsorption of toluene on porous materials with different chemical m composition Synthesischaracterization of activated carbon from modified banana peels PO12 Ben Khalifa Eya [email protected] for hexavalent chromium adsorption [email protected] PO13 Benvenuti Martino The maturation of the co-dehydrogenase from thermococcus sp.
    [Show full text]